U.K. opens center to developing biologics manufacturing processes

The U.K.'s Centre for Process Innovation (CPI) has completed and opened its £38 million ($57.5 million) facility devoted to the research and development of new process for manufacturing biologics. The facility, announced in 2012, is part of the country's effort to improve its standing in the industry. The new National Biologics Manufacturing Centre (NBMC) is in Darlington, Co. Durham. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.